World News

Cancer in My Community: Addressing Health Disparities in Brazil

Ogkologos - 18 Ιουλίου, 2023

Pirtobrutinib Shows Efficacy in Patients with Heavily Pretreated CLL or SLL...

Ogkologos - 18 Ιουλίου, 2023

Lazertinib Demonstrates Significant Efficacy Improvement Compared with Gefitinib in the First-Line...

Ogkologos - 17 Ιουλίου, 2023

Three-Drug Regimen Improves Protection against GVHD after Stem Cell Transplant

Ogkologos - 14 Ιουλίου, 2023

New tool to tackle gaps in public’s knowledge of blood cancer...

Ogkologos - 14 Ιουλίου, 2023

Enfortumab Vedotin Plus Pembrolizumab Shows a High Confirmed Objective Response Rate...

Ogkologos - 14 Ιουλίου, 2023

Aspartame and cancer – sweet nothings?

Ogkologos - 14 Ιουλίου, 2023

Can Using Hair Dyes or Hair Relaxers Impact Your Cancer Risk?

Ogkologos - 13 Ιουλίου, 2023

EMA Recommends Extension of Therapeutic Indications for Sacituzumab Govitecan

Ogkologos - 13 Ιουλίου, 2023

Making Cancer Care More Equitable: A Cancer Survivor’s Story

Ogkologos - 12 Ιουλίου, 2023

1...120121122...432 Σελίδα 121 από 432

MOST POPULAR

Sacituzumab Govitecan Demonstrates a Relatively High ORR with Rapid Responses in...

16 Σεπτεμβρίου, 2024

FDA Approves Dostarlimab-gxly with Chemotherapy for Endometrial Cancer

11 Αυγούστου, 2023

EMA Recommends Granting a Marketing Authorisation for Decitabine / Cedazuridine

31 Αυγούστου, 2023

Empowering People With Cancer: A Q&A With Cancer.Net Editor in Chief...

8 Ιουνίου, 2021

Φόρτωση περισσοτέρων

Cancer in My Community: Addressing Health Disparities in Brazil

Pirtobrutinib Shows Efficacy in Patients with Heavily Pretreated CLL or SLL...

Lazertinib Demonstrates Significant Efficacy Improvement Compared with Gefitinib in the First-Line...

Three-Drug Regimen Improves Protection against GVHD after Stem Cell Transplant

New tool to tackle gaps in public’s knowledge of blood cancer...

Enfortumab Vedotin Plus Pembrolizumab Shows a High Confirmed Objective Response Rate...

Aspartame and cancer – sweet nothings?

Can Using Hair Dyes or Hair Relaxers Impact Your Cancer Risk?

EMA Recommends Extension of Therapeutic Indications for Sacituzumab Govitecan

Making Cancer Care More Equitable: A Cancer Survivor’s Story

MOST POPULAR

Sacituzumab Govitecan Demonstrates a Relatively High ORR with Rapid Responses in...

FDA Approves Dostarlimab-gxly with Chemotherapy for Endometrial Cancer

EMA Recommends Granting a Marketing Authorisation for Decitabine / Cedazuridine

Empowering People With Cancer: A Q&A With Cancer.Net Editor in Chief...

HOT NEWS

How to Tell If Cancer Information on Social Media Is “Fake...

Why ASCO’s Annual Meeting Matters for People With Cancer and How...

Could Bacteria Help Find Cancer?

Stressed out – the cancer cells that survive chemotherapy, but at...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ